Background: Previous estimates of global palliative care development have not been based on official country data. Aim: The World Health Organization Noncommunicable Disease Country Capacity Survey of World Health Organization member state officials monitors countries' capacities for the prevention and control of noncommunicable diseases. In 2015, for the first time, questions were included on a number of palliative care development metrics to generate baseline data for monitoring global palliative care development. Design: Participants were given instructions, a glossary of terms, and 3 months to complete this closed, non-randomized, online survey. Questions were developed through a consultative process with relevant technical World Health Organization departments. Setting/participants: Health ministry officials serving as noncommunicable disease focal points from 177 out of 194 (91%) of World Health Organization Member States completed the voluntary survey. Results: This survey reveals that (a) a minority (37%) of countries have an operational national policy for noncommunicable diseases that includes palliative care, (b) palliative care is least likely to have funding available compared with other core noncommunicable disease services, and (c) there is a large country-income gradient for palliative care funding, oral morphine availability, and integration of palliative care services at the primary levels of the health system. Conclusion: Palliative care for noncommunicable disease patients must be strengthened in a majority of countries. These data provide a baseline for trend measurement of official country-level and global palliative care development. A repeat assessment is taking place in the first half of 2017.
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Original Article
What is already known about the topic?
• • There is both underdevelopment of and lack of access to palliative care almost everywhere. 1 • • Most palliative care services are provided in high-income countries, 2 despite almost 80% of global need being in low-to middle-income countries. 1 • • Previous estimates of global [2] [3] [4] [5] or regional 6, 7 palliative care development have not been based on official country data.
Background
Palliative care is an essential component of the response to noncommunicable diseases 8 and an ethical responsibility of health systems and health care professionals. 9 There is both underdevelopment of and lack of access to palliative care almost everywhere except for a few high-income countries. 1, 4, 10, 11 Yet governments globally have recognized the critical importance of palliative care and the urgent need to improve access to it in the World Health Assembly (WHA) 67.19 resolution on strengthening of palliative care as a component of comprehensive care throughout the life course. 9 The lack of access to palliative care persists despite growing need, driven by an aging global population and an epidemiological transition; many noncommunicable diseases for which palliative care is commonly needed are increasing in prevalence, especially in low-and middleincome countries. [12] [13] [14] [15] Globally, noncommunicable diseases cause 70% of all deaths 16 and generate 93% of adult palliative care need. An estimated 37.4% of all deaths need palliative care. 17 Almost 80% of the global palliative care need is in low-to middle-income countries. 1, 4, 6 Previous estimates of global [2] [3] [4] or regional 6, 7 palliative care development were based on available peer-reviewed publications, books, international and national palliative care directories, websites, associations, medical and nursing educational curricula, other gray literature, and (of particular importance) expert opinion. While useful as snapshots, official country-level global data have not been available until now. We present the first governmentapproved global data on palliative care for patients with noncommunicable diseases as measured by palliative care policies, funding, medicine availability, and integration of palliative care into the primary levels of the health system.
Aim
The WHA67.19 resolution asked the World Health Organization (WHO) to monitor the global status of palliative care and evaluate progress. WHO has carried out periodic global surveys of Member States (2001, 2005, 2010, 2013) to assess capacities for noncommunicable disease prevention and control. This was repeated in 2015 18 and included an expanded set of questions about palliative care. This article presents the country-specific results (Supplementary Table 1 ) and discusses their implications.
Design
Survey participants and data collection, review, and validation
A web-based WHO questionnaire was used to collect data from the noncommunicable disease focal point in each Ministry of Health or from designated colleagues within the health ministry, national institute, or agency responsible for noncommunicable diseases in all WHO Member States (194 countries). Data were collected on a voluntary basis with the agreement of WHO's Member States and did not need institutional review board approval. No incentives were offered for completing the survey. As a closed survey, country officials received their unique ID and log in code to the website in late May or early June 2015 and focal points were requested to submit their completed questionnaire through the WHO website by the end of August 2015. Officials were contacted by email and phone from WHO Regional Offices. The study was not advertised publicly. Instructions requested that a team led by the noncommunicable disease focal point in the Ministry of Health complete the responses so that topic-specific experts could provide more detailed assessment. No personal information was collected or stored. For validation and verification of responses, countries were asked to submit supporting documentation for certain questions. For example, countries were asked whether they have "a national NCD policy, strategy or action plan which integrates several NCDs and their risk factors?" and any country that responded positively was asked to provide copies What this paper adds • • These are the first government-approved global data on palliative care for patients with noncommunicable diseases as measured by palliative care policies, financing, morphine availability, and integration into the primary levels of the health system. • • This survey reveals that (a) a minority (37%) of countries have an operational national policy for noncommunicable diseases that includes palliative care, (b) palliative care is least likely to have funding available compared with other core noncommunicable disease services, and (c) there is a large country-income gradient for palliative care funding, oral morphine availability, and integration of palliative care services in the primary levels of the health system.
Implications for practice, theory, or policy • • Palliative care for noncommunicable disease patients must be strengthened in a majority of countries.
• • These data provide a baseline for trend measurement of official country-level and global palliative care development.
A repeat assessment is taking place in the first half of 2017.
of the documents. All documents provided are available in an online repository. 19 Where country responses and supporting documentation exhibited discrepancies, or if information or documentation was missing, an amended response was sought from the country. In most cases, suggested modifications were adopted by the countries, and the missing data and documents were added to the country's response in the website.
Questionnaire design
The noncommunicable disease questionnaire consisted of four modules: (a) public health infrastructure, partnerships, and multi-sectoral collaboration; (b) policies, strategies, and action plans; (c) health information systems and surveillance; and (d) health system capacity for detection, treatment, and care.
The questions were developed through a consultative process with relevant technical departments in WHO headquarters and regional offices. The survey was not randomized and contained skip patterns dependent on responses to other items. The number of items per page (and the number of pages) varied according to skip patterns. The study gave indication of progress throughout. Participants were able to login multiple times to review and amend answers until the end of data collection. For the first time, questions concerning elements specific to palliative care were included (Table 1) . These questions were chosen to fit within the framework of the overall survey and reflect the priorities emphasized in the WHA67.19 resolution while avoiding adding extra length to the WHO Noncommunicable Disease Country Capacity Survey tool, which could reduce the response rate.
The survey (translated into Spanish, French, and Russian) included detailed instructions and a glossary defining the terms used. Each country followed their own formal review process before submitting their response to WHO.
Analysis
Data were downloaded directly from the web-based platform to an Excel-readable file. Data extraction, cleaning, and analysis were performed by technical units at WHO headquarters. Consistency of responses within a question and its sub-questions was assessed. All statistical analyses, including analysis by WHO region and World Bank income groups (2015 groupings), were carried out using STATA 13 software (Stata Corporation, 2013).
For all analyses, the denominator used was the total number of countries that responded to the survey, either overall or within the regional or income subgroups of interest. Where responses were "Don't know" or left unanswered, it was assumed that the item in question did not exist in the country; thus, "Don't know," "No," and unanswered were treated equally.
Results
In total, 177/194 Member States (91%) responded to the survey. Over 90% of countries in each WHO region responded, with the exception of the African Region at 75%. Full country-level results can be found in Supplementary Table 1 . A summary of country responses by World Bank income groupings is given in Figure 1 and by region in Table 2 .
Palliative care in national noncommunicable disease strategies
A majority of countries report having a national strategy or policy for noncommunicable diseases (86%; n = 153). But few of these respondents report an operational or currently implemented policy that includes palliative care (37%; n = 66).
There was no consistent gradient between countryincome groups. There was some regional variation of countries reporting an operational noncommunicable disease strategy that includes palliative care, ranging from 18% in the South-East Asian region to 54% in the African region.
National funding for palliative care
In all, 64% of countries (n = 113) reported having national funding for palliative care. Two groups of regions emerged ( Table 2 ). The European, South-East Asian, and Western Pacific regions had the largest proportion of countries that had some sort of national funding available for palliative care. A smaller proportion of countries in the African, American, and Eastern Mediterranean regions had funding available for palliative care. 20 There was a steep correlation between World Bank income group and the availability of national funding for palliative care (Figure 1 ). Countries were less likely to have funding for palliative care than for any of the other core noncommunicable disease activities surveyed and the country-income gradient for funding available for noncommunicable disease activities was most marked for palliative care (Figure 2 ).
Access to essential medicines for pain relief
There was a wide range across regions for availability of oral morphine in primary care facilities of the public health system. Overall, "general availability" (i.e. available in over 50% of pharmacies) was low (n = 76/177; 43%). Oral morphine was generally available in less than 20% of primary care facilities in the African, Eastern Mediterranean, and South-East Asian regions. 20 The survey revealed a marked lack of general availability of oral morphine in low-income (n = 4/26; 15%) and lower middle-income settings (n = 6/45; 14%) and was generally available in less than half of upper middle-income countries (n = 23/50; 46%).
Integration of palliative care into the primary levels of the health system
The survey revealed large differences between regions and income groups with regard to provision of palliative care to noncommunicable disease patients at the primary levels of the health system. In total, 81 countries reported that palliative care was generally available to noncommunicable disease patients (i.e. available to at least 50% of patients in need) through primary care (n = 72; 41%) or home-based or community care (n = 64; 36%). Again, there was a strong income gradient. Very few low-income countries reported that palliative care services were available to noncommunicable disease patients through primary care (n = 5; 19%) and home-based or community care (n = 1; 4%). The range in provision of home-based community palliative care was widest between low-and high-income countries (4% and 70%, respectively). No data were collected on the quality, equity, or utilization of these services.
Discussion
Overall survey
This study presents the first-ever global, governmentapproved data on the prevalence of palliative care policies, financing, medicine availability, and integration into the primary levels of the health system for patients with noncommunicable diseases by region and country income. Although restricted to palliative care for noncommunicable disease patients, the results corroborate existing accounts of global palliative care development: that country income is still a strong determinant of palliative care development, that most countries do not have palliative care services integrated with the health system at a primary health care and community level, and that major improvements in policies, implementation, funding, and opioid accessibility are required to achieve universal coverage. 2, 5 Despite providing the first global survey of official data for palliative care availability in the context of national responses to noncommunicable diseases, the only data able to be verified were the existence of national noncommunicable disease policy documents. Verification of other data relied on the knowledge of the team or individual completing the survey. Palliative care experts were not specifically surveyed, as was done in other palliative care mapping studies. [2] [3] [4] 6, 7 The process for gathering this information likely varied across countries, and despite providing a list of definitions, some questions may have been interpreted differently. Accurate data on the existence of policies probably were easy for national health officials to provide, whereas accurate data on opioid availability and palliative care service delivery likely were more difficult to find in countries where they are not collected routinely.
The questionnaire covered all major areas of capacity for noncommunicable disease prevention and control and therefore was very large. To ensure high participation, there was only a small number of questions on palliative care and their level of detail was necessarily low.
The survey assesses several core components of a public health strategy for palliative care: policy, essential medicine accessibility, and palliative care service delivery. However, the survey was not designed to measure other essential aspects of palliative care access and quality. Metrics such as availability and quality of palliative care training; the integration of training into medical, nursing, and pharmacy curricula; the conformity of services with standards of palliative care; and the adequacy of pain control as reported by patients were not surveyed. [21] [22] [23] [24] [25] [26] [27] At 91%, the response rate from governments was high enough to serve as a global baseline for tracking palliative care development. The next WHO Noncommunicable Disease Country Capacity Survey takes place in the first Table 1) can be used by researchers, policy-makers, civil society, and the public to identify the status of palliative care policies and services in specific countries and remind governments of their commitments to provide palliative care as an essential component of comprehensive care for people with noncommunicable diseases. 8 These data also can be used as a starting point for country-level palliative care situational analyses, recommended as part of the WHO public health strategy for implementing palliative care. [28] [29] [30] Palliative care policies
The WHA 67.19 resolution and WHO Global Action Plan for the Prevention and Control of noncommunicable diseases call for greater integration of palliative care into existing health policies and plans. 8, 9 The 2015 WHO Noncommunicable Disease Country Capacity Survey investigated the inclusion of palliative care in national noncommunicable disease policies and strategies. Some countries have other national health care policies or strategies that include palliative care or stand-alone national palliative care policies which may not have been reported in this survey. 7, 31, 32 Nevertheless, these data show that in the critically important area of noncommunicable diseases, much greater attention needs to be given to palliative care policy, consistent with other more general analyses. 2, 5, 7, 33 Neither the comprehensiveness of the palliative care policies nor the extent of implementation were assessed, although the WHO online repository of the policy documents submitted by countries makes some further analysis possible. Explicit national policies for palliative care provide a necessary foundation for palliative care development, but successful policies require universal essential palliative medicine accessibility, routine education of health care workers in palliative care, and widespread implementation.
Palliative care financing
Country-level data on palliative care financing are scarce. This survey did not ask countries for information on the amount or source of funding available for palliative care, or the specific activities for which it was used, but did ask if there is funding specifically for palliative care. It is concerning that palliative care is least likely to have funding compared with other core activities for noncommunicable disease prevention and control across all regions and income groups (Figure 2 ). This suggests that palliative care is under-funded, as measured by the number of countries funding it, and in its prioritization with other noncommunicable disease services. Others have found that even in countries such as Canada and the United Kingdom with well-developed palliative care services, around half of palliative care funding comes from private (charitable or consumer) sources, 1 indicating that greater priority needs to be given to palliative care in funding from government budgets. The WHA67.19 resolution urges governments to ensure adequate domestic funding and allocation of human resources, as appropriate, for PC initiatives, including development and implementation of PC policies, education and training, and quality improvement initiatives, and supporting the availability and appropriate use of essential medicines, including controlled medicines for symptom management. 9 Some previous investigations have evaluated the sources of palliative care funding but have not published the country-specific results. 2, 3 Further investigation is needed to compare the cost of universally accessible palliative care to current funding levels. In summary, while the data from this survey suggest that funding for palliative care activities is scarce (even in high-income countries), more data are also needed on the sources, amounts, and uses of palliative care funding.
Access to essential medicines for pain relief
As most patients in need of palliative care are in the community, a strong oral immediate-release opioid must be accessible not only for hospital inpatients but also must be dispensed by hospital outpatient pharmacies and by pharmacies in the community. While there is a range of essential medicines needed to provide palliative care, access to oral morphine is used in this survey as an indicator of access to essential medicines for palliative care in general. Strong opioids are the recommended treatments for the relief of moderate or severe pain. 34 Oral immediate-release morphine is on the WHO Model List of Essential Medicines 35 and WHO's list of "basic essential NCD medicines for primary health care." 36 The United Nations Economic and Social Council's Commission on Narcotic Drugs' resolutions 37,38 call for a balance between maximizing accessibility of controlled medications like strong opioids for clinical and scientific use and minimizing the risk of diversion and illicit use. Yet data from the International Narcotic Control Board (INCB) show a widespread underuse and lack of access to opioid medications, and this precludes palliative care in the majority of settings. 39 Data presented here indicate that availability of these medications in outpatient and community pharmacies remains low. This is especially marked in low-income and lower middle-income countries, with only 15% and 13% reporting that oral morphine is available in over 50% of pharmacies. The current pandemic of relievable suffering demands that more be done, bearing risks in mind, to increase access to these essential medications at primary care level, especially in low-and middle-income countries.
Implementation of palliative care services
The country-income gradient for the two surveyed metrics of palliative care service delivery and integration indicate that community-based and home-based palliative care for noncommunicable disease patients is seriously lacking in low-income and lower middle-income settings (4% and 13%, respectively), as are palliative care services in primary health care (19% and 20%, respectively). Because palliative care is an essential component of universal health coverage, these metrics should be priorities for future action and investigation, and this is recognized in recent regional analysis for palliative care services in Europe. 40 To achieve full coverage of those in need, not only in hospitals, palliative care must be integrated into community-based primary health care systems. 1 In WHA67.19, Member States recognized "the urgent need to include palliation across the continuum of care, especially at the primary level." 9 Requirements for palliative care at each level of the health care system will vary by country, and like previous global analyses on palliative care service coverage, it has not been possible to compare provision with need. 40 Data on the insurance coverage, quality, and affordability of these services would also inform coverage estimation.
Conclusion
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